Signature Estate & Investment Advisors LLC Invests $210,000 in Axon Enterprise, Inc. (NASDAQ:AXON)

Signature Estate & Investment Advisors LLC purchased a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) in the 3rd quarter, HoldingsChannel reports. The firm purchased 525 shares of the biotechnology company’s stock, valued at approximately $210,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Blue Trust Inc. lifted its position in shares of Axon Enterprise by 987.5% in the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after buying an additional 79 shares during the last quarter. Quent Capital LLC grew its holdings in Axon Enterprise by 1,875.0% during the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after purchasing an additional 75 shares during the last quarter. Asset Dedication LLC bought a new position in shares of Axon Enterprise in the second quarter valued at approximately $47,000. Planning Capital Management Corp lifted its stake in shares of Axon Enterprise by 83.3% in the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after buying an additional 55 shares during the last quarter. Finally, Friedenthal Financial acquired a new position in Axon Enterprise in the 3rd quarter valued at $51,000. Institutional investors own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

AXON has been the subject of a number of recent analyst reports. The Goldman Sachs Group upped their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Needham & Company LLC increased their target price on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Robert W. Baird lifted their price target on Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. JMP Securities increased their price objective on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research report on Thursday, October 31st. Finally, Northland Securities boosted their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $427.83.

Axon Enterprise Stock Performance

NASDAQ AXON opened at $599.35 on Friday. Axon Enterprise, Inc. has a twelve month low of $220.78 and a twelve month high of $624.84. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The stock has a market cap of $45.70 billion, a P/E ratio of 154.87, a PEG ratio of 15.05 and a beta of 0.94. The company’s 50-day simple moving average is $438.79 and its 200 day simple moving average is $357.57.

Insider Buying and Selling at Axon Enterprise

In related news, President Joshua Isner sold 25,811 shares of Axon Enterprise stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $359.84, for a total transaction of $9,287,830.24. Following the completion of the transaction, the president now directly owns 228,166 shares of the company’s stock, valued at $82,103,253.44. This trade represents a 10.16 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Patrick W. Smith sold 80,300 shares of the company’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the sale, the chief executive officer now directly owns 3,015,366 shares in the company, valued at $1,121,052,771.48. This represents a 2.59 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 411,006 shares of company stock valued at $161,360,618. 6.10% of the stock is currently owned by corporate insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.